跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
普罗力 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Denosumab Injection
Approved
生物制品
Denosumab Injection
AMGEN EUROPE B.V.
🇨🇳 National Medical Products Administration
Approval Date
Feb 7, 2025
Approval ID
8kELA0i0lKy
Company
AMGEN EUROPE B.V.
Type
生物制品
Approval Details
Approval Id
8kELA0i0lKy
Approval Number
国药准字SJ20200019
Generic Name
地舒单抗注射液
Generic Name En
Denosumab Injection
Trade Name
普罗力
Drug Type
生物制品
Dosage Form
注射剂
Strength
60mg(1.0ml)/支(预充式注射器)
Reg Date
2025-02-07
Expired Date
2030-02-06
Company Name
AMGEN EUROPE B.V.
Production Company Name
Amgen Manufacturing, Limited
Company Detail Path
/organization/amgen-europe-b-v
Production Company Detail Path
/organization/amgen-manufacturing-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Feb 7, 2025
Approval ID
8kELA0i0lKy
Type
生物制品
Back to NMPA Approvals